Epigenetic editing tools are making therapeutic T cells to better kill cancer.
“We are proud to partner with Kite Pharma to extend the potential application of Epic’s platform for cancer treatment. Epic’s approach is promising for in vivo medicines and may enable next-generation cell therapies to reach a wide range of patient populations.” Amber Salzman, Ph.D., CEO, Epic Bio. Read more here: https://lnkd.in/gCb9-6jJ #epigenetics #CellTherapy #Cancer
This is great and exciting news professor. Congratulations
Eric Guo
1y
Congratulations Stanley! This is very exciting news!
Congrats! Lei Stanley Qi and Amber Salzman !
Sr Territory Sales Manager at BPS Bioscience Inc.
1yThis is really exciting! Congratulations to you and the Epic Bio team!! 🎉